Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
55.36
+3.38 (6.50%)
At close: Oct 2, 2026, 4:00 PM EDT
55.81
+0.45 (0.82%)
After-hours: Oct 2, 2026, 7:43 PM EDT
Eton Pharmaceuticals Market Cap
Eton Pharmaceuticals has a market cap or net worth of $1.58 billion as of October 2, 2026. Its market cap has increased by 191.24% in one year.
Market Cap
1.58B
Enterprise Value
1.58B
1-Year Change
191.24%
Ranking
Category
Stock Price
$55.36
ChartMarket Cap Chart
Since November 13, 2018, Eton Pharmaceuticals's market cap has increased from $105.74M to $1.58B, an increase of 1,396.47%. That is a compound annual growth rate of 40.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.58B | 248.93% |
| Dec 31, 2025 | 453.48M | 27.82% |
| Dec 31, 2024 | 354.78M | 215.68% |
| Dec 29, 2023 | 112.38M | 57.54% |
| Dec 30, 2022 | 71.34M | -32.42% |
| Dec 31, 2021 | 105.56M | -46.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Prestige Consumer Healthcare | 2.21B |
| Bausch Health Companies | 2.17B |
| BioCryst Pharmaceuticals | 2.12B |
| Perrigo Company | 2.09B |
| Alvotech | 2.09B |
| Trulieve Cannabis | 2.06B |
| Xeris Biopharma Holdings | 1.81B |
| ANI Pharmaceuticals | 1.55B |